Literature DB >> 22377971

Protein expression of estrogen receptors α and β and aromatase in myometrium and uterine leiomyoma.

Anelise Olmos Grings1, Vanessa Lora, Gustavo Dias Ferreira, Ilma Simoni Brum, Helena von Eye Corleta, Edison Capp.   

Abstract

BACKGROUND: Leiomyomas are the most common tumors of the female reproductive tract and a major public health problem. The mechanism of tumorigenesis is unknown, but evidence suggests that estrogens regulate cell proliferation and myoma growth. This effect might be due to different amounts of estrogen receptors (ERα and ERβ) in normal and myoma tissues and overexpression of aromatase P450 in myomas.
PURPOSE: To assess protein expression of ERs and aromatase in leiomyomas and normal adjacent myometrium of premenopausal women.
METHODS: Samples were collected from 12 premenopausal women admitted for abdominal hysterectomy due to fibroids.
RESULTS: The protein expression of ERα, ERβ and aromatase was similar in leiomyoma and normal myometrium (p = 0.239, p = 0.695 and p = 0.203, respectively).
CONCLUSIONS: In this analysis of 12 matched leiomyoma and myometrial samples, the data do not support the theory that overexpression ERα, ERβ and aromatase in uterine leiomyomas compared to adjacent myometrium are the cause of tumor growth. The estrogens may exert their growth-stimulatory effects on leiomyomas intermediated by other elements, such as cytokines and growth or apoptosis factors. The effect of estrogen on the growth and development of fibroids is complex and far from being completely understood.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22377971     DOI: 10.1159/000330700

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  7 in total

1.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

2.  Apoplectic leiomyomas: does ethnicity make a difference? a clinicopathologic study.

Authors:  Bradley M Turner; Stewart F Cramer; Debra S Heller; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2021-11-02       Impact factor: 4.064

Review 3.  Human Chorionic Gonadotrophin as a Possible Mediator of Leiomyoma Growth during Pregnancy: Molecular Mechanisms.

Authors:  Veronica Sarais; Greta Chiara Cermisoni; Matteo Schimberni; Alessandra Alteri; Enrico Papaleo; Edgardo Somigliana; Paola Vigano'
Journal:  Int J Mol Sci       Date:  2017-09-20       Impact factor: 5.923

4.  Markers of Cellular Proliferation, Apoptosis, Estrogen/Progesterone Receptor Expression and Fibrosis in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids.

Authors:  Iwona Szydłowska; Marta Grabowska; Jolanta Nawrocka-Rutkowska; Małgorzata Piasecka; Andrzej Starczewski
Journal:  J Clin Med       Date:  2021-02-03       Impact factor: 4.241

5.  Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy.

Authors:  Maria Sztachelska; Donata Ponikwicka-Tyszko; Lydia Martínez-Rodrigo; Piotr Bernaczyk; Ewelina Palak; Weronika Półchłopek; Tomasz Bielawski; Sławomir Wołczyński
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

Review 6.  Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.

Authors:  Andrea Ciavattini; Jacopo Di Giuseppe; Piergiorgio Stortoni; Nina Montik; Stefano R Giannubilo; Pietro Litta; Md Soriful Islam; Andrea L Tranquilli; Fernando M Reis; Pasquapina Ciarmela
Journal:  Obstet Gynecol Int       Date:  2013-09-12

Review 7.  Is ulipristal acetate the new drug of choice for the medical management of uterine fibroids? Res ipsa loquitur?

Authors:  Funlayo Odejinmi; Reeba Oliver; Rebecca Mallick
Journal:  Womens Health (Lond)       Date:  2017-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.